Stay updated on Obeticholic Acid in NASH Clinical Trial
Sign up to get notified when there's something new on the Obeticholic Acid in NASH Clinical Trial page.

Latest updates to the Obeticholic Acid in NASH Clinical Trial page
- Check5 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Non-alcoholic fatty liver disease; no deletions were present.SummaryDifference0.1%
- Check12 days agoChange DetectedUpdated page now includes a government-operating-status notice and a v3.2.0 revision tag; removed the non-alcoholic fatty liver disease topic under MedlinePlus Genetics and the older v3.1.0 tag.SummaryDifference2%
- Check19 days agoChange DetectedIntroducing new Fatty Liver Disease topics (including non-alcoholic) and advancing to revision v3.1.0, while removing older drug-related topics and upgrading the page version.SummaryDifference0.3%
- Check26 days agoChange DetectedThe page has had the topic “Non-alcoholic fatty liver disease” removed from MedlinePlus Genetics. If this topic was part of core content, its removal reduces the range of genetic disorder topics covered.SummaryDifference0.1%
- Check33 days agoChange DetectedVersion bumped to v3.0.2 and the location name standardized to Bourgoin, France, 38300; the 'Back to Top' link was removed.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content.SummaryDifference0.1%
Stay in the know with updates to Obeticholic Acid in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obeticholic Acid in NASH Clinical Trial page.